Allison Betof Warner
0000-0001-6422-2997
Publication & Citation Trends
Most Cited Works
Publications
177 total
Programmed death ligand-1 PET imaging in patients with melanoma: a pilot study
Cited by 2
Semantic Scholar
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants PDF
Cited by 279
OpenAlex
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy) OA
Cited by 3
Semantic Scholar
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐1 OA
Cited by 1
Semantic Scholar
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy OA
Cited by 12
Semantic Scholar
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study OA
Cited by 17
Semantic Scholar
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.
Cited by 4
Semantic Scholar
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis PDF
Cited by 135
OpenAlex
Diversity, Equity, and Inclusion in the Melanoma Research Community OA
Cited by 3
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(80)
CAR-T cell therapy research
(80)
Immunotherapy and Immune Responses
(46)
Cutaneous Melanoma Detection and Management
(44)
Melanoma and MAPK Pathways
(42)
Frequent Co-Authors
Affiliations
Western University
Cancer Prevention Institute of California
Memorial Sloan Kettering Cancer Center
Howard Hughes Medical Institute
Harvard University